Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Biologics & Biosimilars industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
fizer
Amgen
Johnson & Johnson
3sbio
Sanofi
Lilly
AbbVie
Hospira
Mylan
Teva
Merck
CP Guojian Pharmacy
Novo Nordisk
Biotech Pharma
Novartis
Changchun High Tech
Sandoz
Roche
Gelgen Biopharma
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other
Application:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Biologics & Biosimilars Industry Overview
-
1.1.1 Biologics & Biosimilars Market Scope and Market Segments
-
1.1.2 Biologics & Biosimilars Industry Characteristics
-
1.1.3 Global and China Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Biologics & Biosimilars Production Value and Growth Rate (2017-2028)
-
1.2 Global Biologics & Biosimilars Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Antibiotic
-
1.2.2 Enzyme
-
1.2.3 Hormone
-
1.2.4 Non-Patented Biological Reagents
-
1.2.5 Other
-
1.3 Global Biologics & Biosimilars Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Tumor
-
1.3.2 Diabetes
-
1.3.3 Cardiovascular
-
1.3.4 Hemophilia
-
1.3.5 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Biologics & Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Biologics & Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Biologics & Biosimilars Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Biologics & Biosimilars Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Biologics & Biosimilars Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Biologics & Biosimilars Industry Porter's Five Forces Model Analysis
-
2.2.3 Biologics & Biosimilars Industry PEST Analysis
-
2.3 Biologics & Biosimilars Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Biologics & Biosimilars Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Biologics & Biosimilars Industry
Chapter 3 Global and China Biologics & Biosimilars Market, by Manufacturer
-
3.1 Global and China Biologics & Biosimilars Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Biologics & Biosimilars Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Biologics & Biosimilars Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Biologics & Biosimilars Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Biologics & Biosimilars Market Top 3 Players
Chapter 4 Global and China Biologics & Biosimilars Market, by Type (2017-2028)
-
4.1 Biologics & Biosimilars Market Trend, by Type
-
4.2 Global Biologics & Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Biologics & Biosimilars Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Biologics & Biosimilars Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Biologics & Biosimilars Price Trend, by Type (2017-2028)
-
4.3 China Biologics & Biosimilars Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Biologics & Biosimilars Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Biologics & Biosimilars Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Biologics & Biosimilars Price Trend, by Type (2017-2028)
Chapter 5 Global and China Biologics & Biosimilars Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Biologics & Biosimilars Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Biologics & Biosimilars Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Biologics & Biosimilars Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Biologics & Biosimilars Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Biologics & Biosimilars Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Biologics & Biosimilars Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Biologics & Biosimilars Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Biologics & Biosimilars Market Analysis
-
7.1 North America Biologics & Biosimilars Market, by Type
-
7.2 North America Biologics & Biosimilars Market, by Application
-
7.3 North America Biologics & Biosimilars Market Analysis and Forecast, by Country
-
7.3.1 United States Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Biologics & Biosimilars Market Analysis
-
8.1 Europe Biologics & Biosimilars Market, by Type
-
8.2 Europe Biologics & Biosimilars Market, by Application
-
8.3 Europe Biologics & Biosimilars Market Analysis and Forecast, by Country
-
8.3.1 Germany Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Biologics & Biosimilars Market Analysis
-
9.1 APAC Biologics & Biosimilars Market, by Type
-
9.2 APAC Biologics & Biosimilars Market, by Application
-
9.3 APAC Biologics & Biosimilars Market Analysis and Forecast, by Country
-
9.3.1 China Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Biologics & Biosimilars Market Analysis
-
10.1 Latin America, Middle East and Africa Biologics & Biosimilars Market, by Type
-
10.2 Latin America, Middle East and Africa Biologics & Biosimilars Market, by Application
-
10.3 Latin America, Middle East and Africa Biologics & Biosimilars Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Biologics & Biosimilars Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Biologics & Biosimilars Company Profiles
-
11.1 fizer
-
11.1.1 fizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 fizer Biologics & Biosimilars Product Profiles, Application and Specification
-
11.1.3 fizer Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Amgen
-
11.2.1 Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Amgen Biologics & Biosimilars Product Profiles, Application and Specification
-
11.2.3 Amgen Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Johnson & Johnson
-
11.3.1 Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Johnson & Johnson Biologics & Biosimilars Product Profiles, Application and Specification
-
11.3.3 Johnson & Johnson Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 3sbio
-
11.4.1 3sbio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 3sbio Biologics & Biosimilars Product Profiles, Application and Specification
-
11.4.3 3sbio Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 Sanofi
-
11.5.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 Sanofi Biologics & Biosimilars Product Profiles, Application and Specification
-
11.5.3 Sanofi Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Lilly
-
11.6.1 Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Lilly Biologics & Biosimilars Product Profiles, Application and Specification
-
11.6.3 Lilly Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 AbbVie
-
11.7.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 AbbVie Biologics & Biosimilars Product Profiles, Application and Specification
-
11.7.3 AbbVie Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Hospira
-
11.8.1 Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Hospira Biologics & Biosimilars Product Profiles, Application and Specification
-
11.8.3 Hospira Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Mylan
-
11.9.1 Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Mylan Biologics & Biosimilars Product Profiles, Application and Specification
-
11.9.3 Mylan Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Teva
-
11.10.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Teva Biologics & Biosimilars Product Profiles, Application and Specification
-
11.10.3 Teva Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 Merck
-
11.11.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 Merck Biologics & Biosimilars Product Profiles, Application and Specification
-
11.11.3 Merck Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 CP Guojian Pharmacy
-
11.12.1 CP Guojian Pharmacy Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 CP Guojian Pharmacy Biologics & Biosimilars Product Profiles, Application and Specification
-
11.12.3 CP Guojian Pharmacy Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Novo Nordisk
-
11.13.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Novo Nordisk Biologics & Biosimilars Product Profiles, Application and Specification
-
11.13.3 Novo Nordisk Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.14 Biotech Pharma
-
11.14.1 Biotech Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.14.2 Biotech Pharma Biologics & Biosimilars Product Profiles, Application and Specification
-
11.14.3 Biotech Pharma Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.15 Novartis
-
11.15.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.15.2 Novartis Biologics & Biosimilars Product Profiles, Application and Specification
-
11.15.3 Novartis Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.16 Changchun High Tech
-
11.16.1 Changchun High Tech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.16.2 Changchun High Tech Biologics & Biosimilars Product Profiles, Application and Specification
-
11.16.3 Changchun High Tech Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.17 Sandoz
-
11.17.1 Sandoz Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.17.2 Sandoz Biologics & Biosimilars Product Profiles, Application and Specification
-
11.17.3 Sandoz Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.18 Roche
-
11.18.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.18.2 Roche Biologics & Biosimilars Product Profiles, Application and Specification
-
11.18.3 Roche Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.19 Gelgen Biopharma
-
11.19.1 Gelgen Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.19.2 Gelgen Biopharma Biologics & Biosimilars Product Profiles, Application and Specification
-
11.19.3 Gelgen Biopharma Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Biologics & Biosimilars Industry Investment Prospect and Risk Assessment
-
12.1 Biologics & Biosimilars Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Biologics & Biosimilars Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure China Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Global Biologics & Biosimilars Production Value and Growth Rate (2017-2028)
-
Figure China Biologics & Biosimilars Production Value and Growth Rate (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Antibiotic (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Enzyme (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Hormone (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Non-Patented Biological Reagents (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Tumor (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Diabetes (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Cardiovascular (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Hemophilia (2017-2028)
-
Figure Global Biologics & Biosimilars Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Biologics & Biosimilars Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Biologics & Biosimilars Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Biologics & Biosimilars Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Biologics & Biosimilars Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Biologics & Biosimilars Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Biologics & Biosimilars Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Biologics & Biosimilars Market Share, by Manufacturer in 2021
-
Figure Global and China Biologics & Biosimilars Market Share, by Manufacturer in 2022
-
Table Global Biologics & Biosimilars Sales Volume, by Type (2017-2028)
-
Table Global Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Global Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Global Biologics & Biosimilars Sales Value, by Type (2017-2028)
-
Table Global Biologics & Biosimilars Sales Value Share, by Type (2017-2028)
-
Figure Global Biologics & Biosimilars Price Trend, by Type (2017-2028)
-
Table China Biologics & Biosimilars Sales Volume, by Type (2017-2028)
-
Table China Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure China Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table China Biologics & Biosimilars Sales Value, by Type (2017-2028)
-
Table China Biologics & Biosimilars Sales Value Share, by Type (2017-2028)
-
Figure China Biologics & Biosimilars Price Trend, by Type (2017-2028)
-
Table Global Biologics & Biosimilars Sales Volume, by Application (2017-2028)
-
Table Global Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Global Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Table Global Biologics & Biosimilars Sales Value, by Application (2017-2028)
-
Table Global Biologics & Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure Global Biologics & Biosimilars Sales Value Share, by Application (2017-2028)
-
Table China Biologics & Biosimilars Sales Volume, by Application (2017-2028)
-
Table China Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure China Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Table China Biologics & Biosimilars Sales Value, by Application (2017-2028)
-
Table China Biologics & Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure China Biologics & Biosimilars Sales Value Share, by Application (2017-2028)
-
Figure China Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure North America Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Biologics & Biosimilars Production, Import, Consumption and Export (2017-2022)
-
Table North America Biologics & Biosimilars Sales Volume, by Type (2017-2028)
-
Table North America Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure North America Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table North America Biologics & Biosimilars Sales Volume, by Application (2017-2028)
-
Table North America Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure North America Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure United States Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure United States Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Canada Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Europe Biologics & Biosimilars Sales Volume, by Type (2017-2028)
-
Table Europe Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Europe Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Europe Biologics & Biosimilars Sales Volume, by Application (2017-2028)
-
Table Europe Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Europe Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Germany Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure UK Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure UK Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure France Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure France Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Italy Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Spain Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Poland Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Russia Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table APAC Biologics & Biosimilars Sales Volume, by Type (2017-2028)
-
Table APAC Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure APAC Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table APAC Biologics & Biosimilars Sales Volume, by Application (2017-2028)
-
Table APAC Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure APAC Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure China Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure China Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Japan Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure India Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure India Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Biologics & Biosimilars Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Biologics & Biosimilars Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Biologics & Biosimilars Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Biologics & Biosimilars Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Biologics & Biosimilars Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Biologics & Biosimilars Sales Value and Growth Rate (2017-2028)
-
Table fizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table fizer Product Profiles, Application and Specification
-
Table fizer Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Amgen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Amgen Product Profiles, Application and Specification
-
Table Amgen Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Johnson & Johnson Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Johnson & Johnson Product Profiles, Application and Specification
-
Table Johnson & Johnson Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table 3sbio Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table 3sbio Product Profiles, Application and Specification
-
Table 3sbio Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Lilly Product Profiles, Application and Specification
-
Table Lilly Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Hospira Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Hospira Product Profiles, Application and Specification
-
Table Hospira Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mylan Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mylan Product Profiles, Application and Specification
-
Table Mylan Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Product Profiles, Application and Specification
-
Table Teva Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table CP Guojian Pharmacy Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table CP Guojian Pharmacy Product Profiles, Application and Specification
-
Table CP Guojian Pharmacy Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Biotech Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Biotech Pharma Product Profiles, Application and Specification
-
Table Biotech Pharma Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Changchun High Tech Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Changchun High Tech Product Profiles, Application and Specification
-
Table Changchun High Tech Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sandoz Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sandoz Product Profiles, Application and Specification
-
Table Sandoz Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Roche Product Profiles, Application and Specification
-
Table Roche Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Gelgen Biopharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Gelgen Biopharma Product Profiles, Application and Specification
-
Table Gelgen Biopharma Biologics & Biosimilars Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
